Safety, tolerability, pharmacokinetics and pharmacodynarnics of SK-0403, a novel DPP-IV inhibitor, in healthy Japanese subjects

被引：0
|
作者：
Sunami, Yukiko
Yoshioka, Naoya
Hayashi, Ichiro
Ishida, Tsutomu
Ishida, Tomu
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A128 / A129
页数：2
相关论文
共 50 条
  • [31] Clinical Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Darexaban, an Oral Direct Factor Xa Inhibitor, in Healthy Elderly Japanese Subjects
    Kadokura, Takeshi
    Oikawa, Keishi
    Miyata, Koji
    Murase, Toshinobu
    Nakamura, Mashio
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (04): : 328 - 335
  • [32] Clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban, an oral direct factor Xa inhibitor, in healthy Caucasian and Japanese subjects
    Kadokura, Takeshi
    Kashiwa, Makoto
    Groenendaal, Dorien
    Heeringa, Marten
    Mol, Roelof
    Verheggen, Frank
    Garcia-Hernandez, Alberto
    Onkels, Hartmut
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (08) : 431 - 441
  • [33] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects
    Daniela Willen
    Wolfgang Uhl
    Peter Wolna
    Orestis Papasouliotis
    Özkan Yalkinoglu
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 27 - 40
  • [34] Pharmacokinetics and Tolerability of the Novel Myeloperoxidase Inhibitor Mitiperstat in Healthy Japanese and Chinese Volunteers
    Sunnaker, Mikael
    Bhattacharya, Chandrali
    Nelander, Karin
    Aurell, Malin
    Heijer, Maria
    Collen, Anna
    Han, David
    Holden, Julie
    Trebski, Monika
    Garkaviy, Pavlo
    Ericsson, Hans
    CLINICAL DRUG INVESTIGATION, 2024, 44 (11) : 863 - 874
  • [35] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects
    Willen, Daniela
    Uhl, Wolfgang
    Wolna, Peter
    Papasouliotis, Orestis
    Yalkinoglu, Oezkan
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (01) : 27 - 40
  • [36] Safety, tolerability, pharmacokinetics, and pharmacodynamics of multiple doses of apixaban in healthy Japanese male subjects
    Yamahira, Naomi
    Frost, Charles
    Fukase, Hiroyuki
    Yu, Zhigang
    Wang, Jessie
    Pursley, Janice
    LaCreta, Frank
    Hiraoka, Masaki
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2014, 52 (07) : 564 - 573
  • [37] Pharmacokinetics, Safety, and Tolerability of Glecaprevir and Pibrentasvir in Healthy White, Chinese, and Japanese Adult Subjects
    Lin, Chih-Wei
    Dutta, Sandeep
    Ding, Bifeng
    Wang, Tianli
    Zadeikis, Neddie
    Asatryan, Armen
    Kort, Jens
    Campbell, Andrew
    Podsadecki, Thomas
    Liu, Wei
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (12): : 1616 - 1624
  • [38] Tigecycline Pharmacokinetics, Tolerability, Safety, and Effect on Intestinal Microflora in Healthy Japanese Male Subjects
    Yamashita, Noriaki
    Matschke, Kyle
    Gandhi, Ashesh
    Korth-Bradley, Joan
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (05): : 513 - 519
  • [39] Evaluation of the safety, tolerability, and pharmacokinetics of a single bolus injection of daptomycin in healthy Japanese subjects
    Aoki, Ikuo
    Ishikawa, Kensuke
    Wakana, Akira
    Aso, Masako
    Yoshinori, Tomoko
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (3-4) : 170 - 175
  • [40] Efficacy, Safety, and Dose-Response Relationship of Teneligliptin, a Novel DPP-IV Inhibitor, in Japanese Patients with Type 2 Diabetes Mellitus
    Kadowaki, Takashi
    Marubayashi, Fuyuhiko
    Terata, Ryuuji
    Hayashi, Yoshiharu
    DIABETES, 2010, 59 : A156 - A157
12345